According to the largest study to date, researchers reported that after treating 162 patients with an extract of 99% cannabidiol (CBD), for a 12 week period. the intervention reduced motor seizures at a rate similar to existing drugs ( a median of 36.5 percent) and 2% of patients became completely seizure free. Other studies have shown that it can act as an anticonvulsant.

This turn is due to a comprehensive 2015 study aimed at two notoriously difficult manifestations of epilepsy – Dravet syndrome and Lennox-Gastaut syndrome – most often encountered in children. Seizure frequency was found to decrease between 54 percent and 67 percent for the six months cannabidiol medication was used, although a small part of individuals did not continue after three months, as their condition did not improve.
17. Deiana S, Watanabe A, Yamasaki Y, Amada N, Arthur M, Fleming S, Woodcock H, Dorward P, Pigliacampo B, Close S, Platt B, Riedel G. Plasma and brain pharmacokinetic profile of cannabidiol (CBD), cannabidivarine (CBDV), 9-tetrahydrocannabivarin (THCV) and cannabigerol (CBG) in rats and mice following oral and intraperitoneal administration and CBD action on obsessive–compulsive behavior. Psychopharmacology (Berl) 2012;219:859–873. [PubMed] [Google Scholar]
Cunha et al. reported a 2-phase pilot study of CBD versus placebo in normal volunteers and patients with refractory secondarily generalized epilepsy (14). In the first phase, 8 normal volunteers received CBD or placebo in a doubled-blind fashion, at a dose of 3 mg/kg for 30 days. The second phase was also double-blinded in 15 patients with epilepsy receiving 200 to 300 mg daily of CBD or placebo for 135 days. Patients continued baseline AED. All subjects tolerated CBD well, with no serious adverse events. Four of the epilepsy patients receiving CBD were “almost free of convulsive crisis” for the duration of the study. Three other patients receiving CBD had a partial reduction in seizures, and 1 subject had no response. Of the 7 patients receiving placebo, seizure frequency was unchanged in 6, and 1 had clear improvement in seizure control.
And lastly, don’t hesitate to speak with a marijuana doctor or health professional about using CBD oil. And please note,  it is not our goal for any of the information on here to come across as clinical advice or medical recommendations. If you live in a state with legalized medical marijuana, make sure you take full advantage of the resources that are available to you – getting a licensed MMJ card is easier than it has ever been before, and it could very well be one of the best decisions you’ve ever made for yourself.
However, even if you do suffer from one of the above-mentioned chronic conditions, it’s still recommended you start out with the low potency oil first, at least until you gauge how your body reacts to the CBD. It’s important to understand that because everybody’s biochemistry is different, not everyone will react the same or get the same therapeutic effects from CBD oil.
Prescription opioids, such as codeine, hydrocodone, oxycodone, oxymorphone, fentanyl, and morphine are medications that are naturally found in the opium poppy plant. Besides relieving pain, they can make you relaxed and high. The problem is that opioids are highly addictive, and overuse and death are incredibly common as a result of opioids. This is true for prescription opioids, and people taking prescription opioids may become addicted and suffer from consequences. Yet doctors are still commonly prescribing opiods even in less serious cases (17).

And now, onto the thorny issue of legality. The simple answer to the question is yes — if it is extracted from hemp. The 2014 Farm Bill established guidelines for growing hemp in the U.S. legally. This so-called “industrial hemp” refers to both hemp and hemp products which come from cannabis plants with less than 0.3 percent THC and are grown by a state-licensed farmer.


Cannabis has always been a popular form of treatment for a variety of medical conditions, but in the 1930’s growing concerns about the dangers of marijuana abuse led to cannabinoids being banned. A century has past and despite all efforts from cannabis enthusiasts through social media channels and online media, cannabis is still classed as a schedule 1 drug.
For example, both CBD and THC affect the body’s endocannabinoid system and thus provide relief for many of the same conditions. CBD is used for more “serious ailments.” Including but not limited to seizures, psychosis or mental disorders and inflammatory bowel disease. The reason for that is that CBD doesn’t get you “high.” In fact, it would be impossible for a person to get high while using CBD because as we said above, it interferes with the CB1 receptors.
CBD is suddenly everywhere — and it’s not hard to see why. It won’t get you high, has a good safety profile, and naturally treats dozens of conditions. But there’s a dizzying amount of choice out there, so we’ve ranked the 25 best CBD oils to help you get started. Whether you’re a rank beginner, or you’ve been experimenting with CBD for a while, we’ve got you covered.
CBD Vape Oil is very popular and can be used with a suitable vaporizer. Since this oil is generally viscous, it needs a device that can work with it. Therefore, it cannot be used with all vaporizers. Make sure you have a suitable vaporizer before using a CBD vape oil. CBD Vape oils have different concentrations and flavors. Adding terpenes also contributes to the effect.
CBD hemp oil has a number of uses and comes in many forms including capsules, tinctures, sublingual supplements, liquid oil, oil as a paste, sprays, salves, creams and in edible forms, such as candies or sweets. You can also inhale CBD oil from vapor-releasing pens, similar to the technology for e-cigarettes. This variety also provides a lot of controlled flexibility in terms of concentration, making CBD hemp oil useful and desirable for people of all ages, economic means, and personal needs.
The immediate and powerful effects of THC are explained because of the special affinity it has with the CB1 type receptors, which mediate crucial processes in the brain. The less prominent (but no less important) action of CBD was explained, at least for a while, by hypothesizing that it binds to CB2 type receptors, hence its more diffuse manner of exercising changes in the body. Early on, the antipsychotic effects of cannabidiol were observed, an aspect which seemed to be in consonance with this initial hypothesis.
Another major reason why CBD oil has been positively received in some parts of the medical community is its apparent effect on cancer and tumor growth.A study done by the researchers of the Institute of Toxicology and Pharmacology, University of Rostock, Germany recommends the use of CBD oil (even direct injection into tumors) to eliminate or reduce the size of the tumors. The antioxidants in CBD hemp oil also provide anti-mutagenic properties and lower users’ risk of cancer.

At the most basic level, CBD interacts with the body’s endocannabinoid system and is widely believed to directly impact the brain’s CB1 receptors – the same receptors that certain anxiety medications interact with – lessening the effects of anxiety and related conditions. This allows sufferers to live more normal lives, free from the constraints of anxiety. That’s just the tip of the iceberg… the positive effects of CBD for anxiety are incredible!
Studies have demonstrated that CBD has a low affinity for the CB1 receptors, but even at low concentrations, CBD decreases G-protein activity (3). CB1 receptors are expressed on many glutamatergic synapses that have been implicated in seizure threshold modulation. CBD may act at CB1 receptors to inhibit glutamate release (4). Studies have shown changes in the expression of CB1 receptors during epileptogenesis and after recurrent seizures (5). CB1 receptor expression is upregulated at GABAergic synapses and shown to be downregulated at glutamatergic synapses in epilepsy, contributing to lowering seizure thresholds.
Unfortunately, conventional treatments for chronic pain are incredibly expensive. Medications may not be effective enough, yet come with an array of side effects and health risks. Fortunately, there are a variety of options to prevent, manage, and lower pain, including chronic pain through natural means, such as an anti-inflammatory diet, stress-reduction strategies, exercise, and bodywork.
Over the past few years, increasing public and political pressure has supported legalization of medical marijuana. One of the main thrusts in this effort has related to the treatment of refractory epilepsy—especially in children with Dravet syndrome—using cannabidiol (CBD). Despite initiatives in numerous states to at least legalize possession of CBD oil for treating epilepsy, little published evidence is available to prove or disprove the efficacy and safety of CBD in patients with epilepsy. This review highlights some of the basic science theory behind the use of CBD, summarizes published data on clinical use of CBD for epilepsy, and highlights issues related to the use of currently available CBD products.

People who experience psychosis may produce too much or even too little cannabinoids (from overactive dopamine receptors). CBD is milder than our internal cannabinoids and helps to re-establish a balance of cannabinoids in the brain. CBD also helps lower inflammation, which is often increased in schizophrenia. THC, on the other hand, is stronger than our internal cannabinoids (anandamide and 2-AG), this way potentially triggering psychosis [46, 48].


Researchers found that CBD helps with a multitude of health issues. These include anxiety, epilepsy/seizure, colitis, psychotic disorders, stroke rehabilitation, PTSD, liver injury and pain relief. The first CBD-based drug Epidiolex approved by the FDA was introduced to the market this year. It is used as a treatment for Lennox-Gastaut syndrome and Dravet syndrome.
If you’re wondering what the function of the prefrontal cortex is, let us tell you. The prefrontal cortex is responsible for decision-making, attention, and other executive tasks, including motor skills. That means that when you consume THC, any of the above areas can be affected. For example, anecdotal evidence suggests that when people are “high,” they experience euphoria, time lapses, the decline in motor skills and mostly hunger.

Everyone has experienced pain in their lives. We encounter a variety of short-term, acute pain on a regular basis. However, over 50 million people in the United States are experiencing some form of chronic pain due to various health issues or for no reason at all. Pain may affect your work, studies, social life, family life, and personal life. It may even lead to disability down the road.
If you haven’t been bombarded with CBD marketing or raves about it from friends, get ready. This extract—which comes from either marijuana or its industrial cousin, hemp—is popping up everywhere. There are CBD capsules, tinctures, and liquids for vaping plus CBD-infused lotions, beauty products, snacks, coffee, and even vaginal suppositories. Already some 1,000 brands of CBD products are available in stores—and online in states that don’t have lenient cannabis laws. This is a tiny fraction of what’s to come: The CBD market is poised to exceed $22 billion by 2022, per the Chicago-based research firm Brightfield Group.
The heat is very much on CBD oil sellers these days as the FDA continues to crack down on companies selling “questionable” (to put it nicely) hemp-based products. In fact, since 2015 – when the FDA first issued warning letters to multiple CBD sellers – the industry has been forced to clean up its act, at least in terms of manufacturing operations and brand transparency.
It all starts with the connection between the endocannabinoid system and intestinal function/motility. Recent studies have found that the transmitters regulated by the endocannabinoid system are located throughout the human body. Some of these transmitters are responsible for gut function; when imbalanced, negative effects are likely to occur. (41)
CBD is well tolerated in humans with doses up to 600 mg not resulting in psychotic symptoms (15). In the few small placebo-controlled studies performed, no significant CNS effects were noted. Oral CBD undergoes extensive first-pass metabolism via CYP3A4, with a bioavailability of 6%. Following single doses in humans, the half-life of CBD when taken orally is about 1 to 2 days.1 In vitro studies have shown that CBD is a potent inhibitor of multiple CYP isozymes, including CYP 2C and CYP3A (16, 17). Whether these in vitro observations are relevant at plasma concentrations likely to be seen in patients is unclear. In addition, given its metabolism via CYP3A4, clinical trials of CBD in patients receiving enzyme-inducing AEDs, such as carbamazepine or phenytoin, will require detailed pharmacokinetic studies.
The most efficient way to deliver CBD into the body is through inhalation. That’s because more of the product, and thus more of the active components of CBD are distributed in the bloodstream. However, you should be aware that they pass through the human system in a few hours. Note of reference, CBD is very different from THC, because CBD does not act as a psychoactive substance and doesn’t produce “a high.”
People who experience psychosis may produce too much or even too little cannabinoids (from overactive dopamine receptors). CBD is milder than our internal cannabinoids and helps to re-establish a balance of cannabinoids in the brain. CBD also helps lower inflammation, which is often increased in schizophrenia. THC, on the other hand, is stronger than our internal cannabinoids (anandamide and 2-AG), this way potentially triggering psychosis [46, 48].
×